Oral administration of curcumin (curcuma Longa) can attenuate the neutrophil inflammatory response in zymosan-induced arthritis in rats by Nonose, N. et al.
UNIVERSIDADE ESTADUAL DE CAMPINAS
SISTEMA DE BIBLIOTECAS DA UNICAMP
REPOSITÓRIO DA PRODUÇÃO CIENTIFICA E INTELECTUAL DA UNICAMP
Versão do arquivo anexado / Version of attached file:
Versão do Editor / Published Version
Mais informações no site da editora / Further information on publisher's website:
https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502014001100727
DOI: 10.1590/S0102-86502014001800006
Direitos autorais / Publisher's copyright statement:
©2014 by Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia. All 
rights reserved.
DIRETORIA DE TRATAMENTO DA INFORMAÇÃO
Cidade Universitária Zeferino Vaz Barão Geraldo
CEP 13083-970 – Campinas SP
Fone: (19) 3521-6493
http://www.repositorio.unicamp.br
Acta Cirúrgica Brasileira - Vol. 29 (11) 2014 - 727
6 - ORIGINAL ARTICLE
MODELS, BIOLOGICAL
Oral administration of curcumin (Curcuma longa) can attenuate the neutrophil 
inflammatory response in zymosan-induced arthritis in rats1
Nilson NonoseI, José Aires PereiraII, Paulo Roberto Moura MachadoIII, Murilo Rocha RodriguesIV, Daniela Tiemi SatoIV, Carlos 
Augusto Real MartinezV
DOI: http://dx.doi.org/10.1590/S0102-86502014001800006
IFellow Master degree, Postgraduate Program in Health Sciences, Sao Francisco University (USF), Bragança Paulista-SP, Brazil. Technical procedures, 
acquisition and interpretation of data, manuscript preparation.
IIAssistant Professor, Department of Pathology, USF, Bragança Paulista-SP, Brazil. Histopathological examinations and histological analysis. 
IIIPhD, Assistant Professor, Department of Orthopedics, Sao Francisco University Medical Hospital (HUSF), Bragança Paulista-SP, Brazil. Technical 
procedures, acquisition of data, critical revision.
IVGraduate student, USF, Bragança Paulista-SP, Brazil. Scientific initiation student, Grant from Institutional Program for Scientific Initiation (PIBIC) 
of the National Council of Technological and Scientific Development (CNPq), Ministry of Science, Technology and Innovation, Brazil. Technical 
procedures, acquisition of data.
VAssociate Professor, Postgraduate Program in Health Sciences, USF, Bragança Paulista-SP. Associate Professor, Campinas State University 
(UNICAMP), Brazil. Conception and design of the study, manuscript writing, supervised all phases of the study, critical revision.
ABSTRACT
PURPOSE: To evaluate the effect of curcumin in the acute phase of zymosan-induced arthritis.
METHODS: Twenty-eight male rats were subjected to intra-articular infiltration of zymosan of both knees and, in four the infiltration 
was made with saline. The animals were divided into five groups second received every six hours by gavage: corn oil by (positive and 
negative control); curcumin (100 mg/kg); prednisone 1 mg/kg/day; prednisone 8 mg/kg. All animals were sacrificed after six, 12, 24 and 
48 hours of the infiltration. The knees were removed for evaluation of neutrophil infiltration. The number of neutrophils was counted 
by computer-assisted analysis of the images. The neutrophil infiltrate was stratified into four grades: 0 = normal; + = mild; ++/+++ = 
moderate; > ++++ = severe. The results were compared using the Mann-Whitney test and the variance by Kruskal-Wallis test adopting 
a significance level of 5% (p<0.05).
RESULTS: Curcumin reduces inflammatory activity in the first six hours after zymosan-induced arthritis when compared to saline 
(p<0.01). This was also observed in animals subjected to administration of prednisone (1 mg/kg) and those treated with prednisone (8 
mg/kg). Curcumin was more effective than lower doses of prednisone in the first six hours after induction of the arthritis. After 12, 24 
and 48 hours, curcumin does not have the same anti-inflammatory effects when compared to prednisone. After 48 hours, prednisone is 
more effective than curcumin in reducing the inflammatory infiltrate regardless of the dose of prednisone used.
CONCLUSION: Oral administration of curcumin reduces inflammation in the first six hours after experimentally zymosan-induced arthritis.
Key words: Arthritis, Experimental. Zymosan. Curcumin. Prednisone. Neutrophil Infiltration. Numerical Analysis, Computer-Assisted. Rats.
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Introduction
Arthritis is a degenerative joint disease with a high 
prevalence and is a major cause of disability worldwide1. The 
continuous inflammatory process leads to progressive destruction 
of the cartilage, bone changes and chronic inflammation of the 
synovial membranes. The intense and continuous pain in the 
involved joints limits movements and results in the patient 
becoming depressed and isolated from his/her social life2,3. 
In addition to interfering with the quality of life, arthritis has a 
substantial impact on treatment and medical care costs4.
Arthritis can affect any joint. However, in descending 
order, the knees are the most commonly affected joints, followed 
by the hips, hands, spine, wrists and ankles3. It is estimated that 
35% of individuals over 30 years of age already show clinical and 
radiological signs of arthritis in the knees and that 85% of patients 
over 70 years of age have radiographic changes in their knee joints 
that allow the diagnosis of disease1,3. Although the etiology of 
arthritis is still uncertain, some risk factors have been related to its 
pathogenesis, including age, endocrine and metabolic disorders, 
ethnic, genetic and mechanical trauma1. 
Symptoms in patients with arthritis are related to 
joint wear, synovitis of repetition, degeneration of ligaments, 
joint capsule changes, osteoporosis, presence of joint effusion, 
and most likely the formation of crystal deposits (apatite) in 
the synovial membrane. Pain is the primary and dominant 
symptom in patients with arthritis of any kind. It features 
variable intensity according to the phase of the disease and may 
be cyclic or constant, and it is worse with joint movement and 
improves with rest. In mild forms, the pain appears only after 
application of pressure on the involved joint, and it improves 
with rest and analgesics or nonsteroidal anti-inflammatory 
drugs (NSAIDs). With the progression of the frame, pain 
becomes more intense, with patients requiring higher doses of 
anti-inflammatory medications and having shorter pain-free 
intervals. In severe forms, pain arises even at rest, which makes 
any attempt of motion impossible; therefore, the patient needs to 
use stronger analgesics, including opioids and glucocorticoids 
(GC). Patients are frequently also treated with GC by mouth or 
by joint infiltration as well as with immunosuppressive drugs 
and more recently monoclonal anti-TNF-α. With the progressive 
degeneration of articular cartilage, inflammation by continuous 
stiffness is of variable length, resulting in limitation of motion 
and crepitus of the joint during flexion and extension.
Studies in experimental models of arthritis have shown 
that neutrophils are the first cells to migrate into the joint5. 
The activated neutrophils promote phagocytosis of immune 
complexes formed in the early stages, releasing reactive oxygen 
species (ROS) and thus leading to an oxidative stress on the 
articular cartilage and eicosanoids that increase the production of 
proinflammatory cytokines5. The inflammatory response causes 
an increase in blood flow and local transudation of histamine 
and serotonin, thereby increasing the neutrophil infiltration, with 
consequent overproduction of ROS. Studies have shown that in 
the pathogenesis of arthritis, damage to the cartilage is related 
to oxidative stress caused by the excessive formation of ROS, 
as well as by blocking or reducing the signaling pathways of 
antioxidant systems6,7.
To relieve limiting painful symptoms, most patients use 
anti-inflammatory and analgesic medications in a continuous 
manner. For ease of acquisition and the concomitant analgesic, 
anti-inflammatory hormonal and non-steroidal drugs are 
commonly consumed. Chronic use of these substances, often 
without medical supervision, at a high dosage for long periods 
results in serious adverse effects on the digestive, renal, cardiac 
and hematologic systems. Finding natural substances with 
potential antioxidant effects that also have anti-inflammatory and 
analgesic effects and low rates of side effects is an old aspiration. 
New substances are constantly being tested, showing activity 
against arthritis both in vitro and in vivo. 
A natural substance that has shown amazing effects for 
the treatment of osteoarthritis is curcumin, the active ingredient 
extracted from the root of Curcuma longa (Indian curry), which was 
already used by Ayurvedic medicine8. Among the many potential 
uses of the curcumin, its intense antioxidant activity stands out9,10. 
When considering that there is a significant formation of ROS by 
the synovium in patients with arthritis, it is possible that curcumin 
will be useful in treating this disease11. It is possible that the 
antioxidant effects of curcumin can minimize oxidative damage 
to the articular cartilage and improve the symptoms of the disease. 
However, to the best of our knowledge, the anti-inflammatory 
effects of curcumin have not been tested in experimental models 
of zymosan-induced arthritis12-14. Thus, the aim of this study was 
to determine whether oral administration of curcumin enhances 
the acute inflammatory response in experimental arthritis.
Methods
This study was approved in accordance with Federal 
Law No. 11.794 (10/08/2008) and the Ethics Committee in Animal 
Research of Sao Francisco University receiving the certificate No. 
003.06.11 (09/ 22/2011). 
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Forty male SPF Wistar rats (300-350g) were obtained 
from the central vivarium of the Sao Francisco University 
School of Medicine. The rats were maintained under 12-hour 
light/dark cycles and fed a standard rodent chow diet. The 
animals were deprived of food, but not water, for 12 hours prior 
to the surgical procedure. 
Arthritis induction
The experiment was started at 6 o’clock in the morning. 
The animals were initially weighed, and the induction of arthritis 
was always performed under general anesthesia by intraperitoneal 
administration of 0.1 ml/100 g of a 1:1 (v/v) solution of ketamine 
(50 mg/ml) and xylazine (20 mg/ml). The induction of the arthritis 
was performed on 24 animals of the experimental group and four 
of the positive control group by infiltration of 0.05 mL zymosan (1 
mg/50 µL) in both knee joints using disposable insulin syringes. 
Four animals of the negative control group received the same 
intra-articular volume of saline.
Experimental groups
The animals were divided into the following five groups: A) 
Positive control: after the induction of arthritis, the animals received 
gastric gavage with corn oil every six hours for 48 hours (n=4); B) 
Negative control: the rats received intra-articular infiltration with 
saline in both knees and gastric gavage with corn oil every six hours 
for 48 hours (n=4); C) Curcumin: after the induction of arthritis, the 
animals received gastric gavage every six hours for 48 hours with 
curcumin (Sigma-Aldrich Ltd., USA) at dose 100 mg/kg (n=8); 
D) after the induction of arthritis, the rats received gastric gavage 
every six hours for 48 hours with prednisone at dose of 1 mg/kg/day 
(n=8); E) after the induction of the arthritis, the animals received 
gastric gavage every six hours for 48 hours with prednisone at dose 
of 8 mg/kg/day (n=8). The animals in all experimental groups were 
sacrificed after six, 12, 24 and 48 hours. 
After sacrifice, tissue samples containing the cartilage 
and synovial of both knees were removed. Fragments prepared 
for histological analysis were immersed in 10% neutral buffered 
formalin (Sigma, St. Louis, MO, USA) for 24 h, dehydrated in 
increasing ethanol concentrations, and embedded in paraffin. 
Thereafter, 5-µm sections of tissue were cut using a rotary 
microtome (Leica Biosystems, Nussloch, Germany), mounted on 
glass slides, cleared, hydrated and stained with hematoxylin-eosin 
(HE) for histological evaluation. Slide analysis was performed 
by a pathologist experienced in arthritis who was unaware 
of the source material and the objectives of the study using an 
optical microscope (Eclipse DS-50, Nikon Inc., Osaka, Japan). 
Photomicrographs were taken with a digital video-capture camera 
(DS-Fi-50; Nikon Inc., Osaka, Japan) coupled to the microscope 
body. The number of neutrophils per field was measured by 
computer-assisted image analysis system (NIS-Elements; Nikon 
Inc., Osaka, Japan), evaluating the image of three random fields in 
each histological slide. The final value adopted for each slide was 
represented by the median of the values  found in the evaluation of 
the three selected fields.
 The intensity of the inflammatory infiltrate was graded 
in crosses (from - to 6+) according to the number of neutrophils 
founded in each histological fields. The final value adopted 
for each animal was the average found after analysis of three 
distinct histological fields and represents the inflammatory grade. 
According to the points obtained in the inflammatory grade, 
graduation was stratified as absent (0), mild (1 and 2), moderate 
(3 and 4) and severe (5 and 6), to what is called the degree of 
inflammation (Table 1).
Degree of inflammation Score Histological characteristics
Absent 0 normal
Mild 1-2 Mild intensity
Moderate 3-4 Moderate intensity
Severe 5-6 Severe intensity
TABLE 1 - Grading scale of degree of the inflammation.
The statistical analysis of the obtained results was 
performed using a significance level of 5% (p<0.05). The data 
obtained from the analyzed colon segment in each experimental 
group were expressed as the mean values and the respective 
standard error using SPSS statistical software version 13.0 (SPSS 
Inc., Chicago, USA) for Windows. Significant results are marked 
with a simple asterisk when p<0.05 and with a double asterisk 
when p<0.01. The Mann-Whitney test was used to compare 
inflammation scores between the control and experimental animal 
groups. The Kruskal-Wallis test was used to analyze the variance 
in the degree of inflammation between the different groups. 
Results
Figure 1A shows the synovial membrane and articular 
cartilage removed from a normal animal’s knee in the negative 
control group (not subjected to infiltration with zymosan). Figure 
1B shows the articular cartilage and the synovia of a knee removed 
from an animal in the control positive group after six hours of 
gastric gavage with corn oil. 
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Figure 2A shows the articular cartilage and synovial 
membrane removed from an animal in the experimental group 
subjected to gastric gavage with curcumin (100 mg/kg) after six hours 
of articular-induced arthritis with zymosan. Figure 2B shows the 
articular cartilage and synovial membrane removed from an animal 
in the experimental group subjected to gastric gavage with curcumin 
(100 mg/kg) after 48 hours of articular-induced arthritis with zymosan.
Figure 4A shows the articular cartilage and synovial 
membrane removed from an animal in the experimental group 
subjected to gastric gavage with prednisone (8 mg/kg) after six hours 
of induction of arthritis with zymosan. Figure 4B shows the articular 
cartilage and synovial membrane removed from an animal in the 
experimental group subjected to gastric gavage with prednisone (8 
mg/kg) after 48 hours of articular-induced arthritis with zymosan.
FIGURE 1 - A: Synovial membrane and articular cartilage from 
animal’s knee after six hours of negative control group showing 
without neutrophil infiltration (HE x100). B: Synovial membrane 
and articular cartilage from animal’s knee after six hours of positive 
control group showing severe neutrophil infiltrate (HE x100).
FIGURE 2 - A: Synovial membrane and articular cartilage from 
animal’s knee after six hours of curcumin (100 mg/kg) oral gavage 
showing mild neutrophil infiltration (HE x100). B: Synovial 
membrane and articular cartilage from animal’s knee after 48 hours 
of curcumin (100 mg/kg) oral gavage showing severe neutrophil 
infiltration (HE x100).
Figures 3A shows the articular cartilage and synovial 
membrane removed from an animal in the experimental group 
subjected to gastric gavage with prednisone (1 mg/kg) after six hours 
of induction of arthritis with zymosan. Figures 3B shows the articular 
cartilage and synovial membrane removed from an animal in the 
experimental group subjected to gastric gavage with prednisone (1 mg/
kg) after 48 hours of articular-induced arthritis with zymosan.
FIGURE 3 - A: Synovial membrane and articular cartilage from 
animal’s knee after six hours of prednisone (1 mg/kg) oral gavage 
showing moderate neutrophil infiltration (HE x100). B: Synovial 
membrane and articular cartilage from animal’s knee after 48 
hours of prednisone (1 mg/kg) oral gavage showing moderate 
neutrophil infiltration (HE x100).
FIGURE 4 - A: Synovial membrane and articular cartilage from 
animal’s knee after six hours of prednisone (8 mg/kg) oral gavage 
showing mild neutrophil infiltration (HE x100). B: Synovial 
membrane and articular cartilage from animal’s knee after 48 
hours of curcumin (100 mg/kg) oral gavage showing moderate 
neutrophil infiltration (HE x100).
Table 2 shows the mean values with their respective 
standard errors and the inflammatory scores at six, 12, 24 and 48 
hours after gavage with corn oil, curcumin (100 mg/kg), and the 
different concentrations of prednisone (1 mg/kg, 8 mg/kg).
Mean ± Standard Error




6 5.75±0.25 2.33±0.42** † 4.33±0.42* 2.16±0.16††
12 5.75±0.25 5.75±0.25 4.00±1.20 4.75±0.47
24 5.75±0.25 5.75±0.25 5.50±0.28 5.50±0.28
48 5.75±0.25 5.75±0.25 3.50±1.40 3.50±1.40
TABLE 2 - Degree of inflammation score after 
intervention with corn oil, curcumin, prednisone (1 mg/kg) and 
prednisone (8 mg/kg) in the knee arthritis induced by zymosan.
mg/kg, milligrams/kilograms. * = p<0.05 (control × prednisone 1 mg/kg); ** = 
p<0.01 (control × curcumin and control × prednisone 8 mg/kg), † = p<0.05 (cur-
cumin × prednisone 1 mg / kg); †† = p<0.01 (prednisone 1 mg / kg × prednisone 8 
mg/kg). Mann-Whitney test.
Table 3 shows the variations in the inflammatory scores 
in animals of the positive control and experimental groups 
subjected to gastric gavage with corn oil, curcumin (100 mg/kg), 
and different concentrations of prednisone (1 mg/kg, 8 mg/kg) at 
different time points during the experiment.
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Discussion
The main objective of the treatment of different forms 
of arthritis is to reduce inflammation within the joints15. There are 
several drugs that meet that goal, and among them, substances 
that interrupt the inflammatory cascade deserve a prominent 
place. For decades, the use of substances with anti-inflammatory 
action has been the main treatment option. The anti-inflammatory 
medications can be divided into the following two major groups: 
steroids and non-steroids substances. 
Different types of GC mainly represent the steroids class. 
GC are hormones produced and secreted by the cortical region 
of the adrenal glands and are involved in various physiological 
functions and adaptation to stress15. Cortisol or hydrocortisone is 
the main circulating GC produced by humans, and its synthesis is 
regulated by the pituitary hormone adrenocorticotropic hormone 
(ACTH), which is released in response to stimulation by a 
neuropeptide called corticotrophin-releasing factor produced in 
the hypothalamus. Cortisol and its synthetic analogues are well 
absorbed from the gastrointestinal tract, and its intra-articular use 
is often performed by rheumatologists and orthopedists when other 
systemic actions of these drugs are unwanted. Continued use of 
GC is associated with various side effects, mainly represented by 
the development of peptic ulcers associated with gastrointestinal 
bleeding, congestive heart failure, cardiac edema in the lower 
limbs, osteoporosis, immune suppression and Cushing’s syndrome.
Anti-inflammatory non-steroidal (AINS) medications 
are substances that block cyclooxygenase, thereby preventing 
the synthesis of eicosanoids by the metabolic pathway of the 
arachidonic acid cascade15. Despite being universally effective and 
used in the form of mild and moderate arthritis, the use of AINS is 
limited due to the high incidence of side effects such as digestive 
disorders (acute gastric mucosal lesions, gastrointestinal bleeding 
and peptic ulcer), severe anaphylactic reactions, kidney failure, 
abnormal platelet aggregation, bleeding diathesis and myocardial 
infarction.
With the aim of finding natural substances that exhibit 
anti-inflammatory activity in the treatment of arthritis and that 
exhibit minimal side effects, the efficacies of a number of natural 
substances are being increasingly tested in experimental models of 
arthritis16,17. Among these substances, curcumin, derived from the 
root of the plant Curcuma longa, which is rich in diferuloylmethane, 
has been one of the most promising natural active ingredients17-19. 
Its use for the treatment of various inflammatory diseases, 
including arthritis, has already been described for thousands of 
years by Ayurvedic medicine and traditional Chinese medicine11. 
The active ingredient was identified more than two centuries 
ago20. Curcumin has a potent immunomodulatory effect on 
the inflammatory response and may regulate the activation 
of T lymphocytes, B-lymphocytes, macrophages, neutrophils 
and dendritic cells. Recent studies have demonstrated that 
curcumin can also decrease the tissue expression of various pro-
inflammatory cytokines, including TNF-α. IL-1, IL-2, IL-6, IL-
12, and inactivating transcription factor NF-kB and, at low doses, 
stimulate antibody production21-23. These effects appear to confirm 
the potential of curcumin for the treatment of arthritis in human 
and experimental models of induced-arthritis24-26.
Several experimental animal models have investigated 
the anti-inflammatory effects of curcumin. Initial studies 
evaluating its effect on carrageenan-induced edema in the fat 
pads of rats’ paws confirmed that doses between 50 and 200 mg/
kg were able to reduce tissue swelling. Experimental models in 
mice showed that 50% curcumin reduces local edema at a dose 
of 48 mg/kg, and a similar effect is observed with similar doses 
of cortisone and phenylbutazone. In addition, doses of 20-80 
mg/kg reduced edema and inflammatory infiltrate in rats. The 
administration of curcumin also inhibits formaldehyde-induced 
arthritis in rats at a dose of 40 mg/kg, and this dose has negligible 
levels on peptic ulcer formation compared to phenylbutazone, and 
without any acute toxicity at doses of up to 2 g/kg27. A double-
blind, randomized controlled trial compared the administration of 
curcumin with phenylbutazone. After administration of 1.200 mg/
day of curcumin, the authors found improvement in joint swelling, 
morning stiffness and increased length of ambulation in patients 
with severe rheumatoid arthritis28. However, few studies have 
evaluated the effects of curcumin on acute inflammatory changes 
of articular cartilage in experimental arthritis25,29-32. Despite 
curcumin being used for centuries in Indian medicine as an anti-
inflammatory substance, evaluation of its therapeutic effects in 
Hours
Hours 6 12 24 48
Corn oil 5.75±0.25 5.75±0.25 5.75±0.25 5.75±0.25
Curcumin 2.33±0.42** 5.25±0.25 5.75±0.25 5.75±0.25
Prednisone 
(1 mg/kg/day)
4.33±0.42 4.00±1.20 5.50±0.28 3.50±1.40*
Prednisone 
(8 mg/kg/day)
2.16±0.16** 4.75±0.47 5.50±0.28 3.50±1.40
TABLE 3 - Degree of inflammation score after intervention 
with corn oil, curcumin, and different concentrations of prednisone 
(1 mg/kg, 8 mg/kg) in knee arthritis induced by zymosan.
mg/kg, milligrams/kilograms. Kruskal-Wallis test. * = p<0.05 (48 hours × 6, 12 
and 24 hours); ** = p<0.01 (6 hours × 12, 24 and 48 hours).
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experimental arthritis has been limited33. No studies have evaluated 
the effects of curcumin in an experimental arthritis model induced 
by zymosan or compared the effects of substance with prednisone, 
which makes this a pioneer study.
Some studies have evaluated the effects of curcumin alone 
or combination with other medications with anti-inflammatory 
effects. Taty Anna et al.19, evaluated increasing doses of curcumin 
(30, 60 and 110 mg/mL/kg) associated with GC (betamethasone 
at a dose of 0.5 mg/mL/kg) applied orally daily for four weeks 
in an experimental model of collagen-induced arthritis. They 
showed that there was significant improvement in inflammatory 
score, radiographic score and erythrocyte sedimentation rate 
in animals treated with the higher doses. However, the main 
criticism is that the study cannot evaluate if the effect is due to 
curcumin alone or, more likely, the synergism between the two 
substances. Ramadan et al.22, compared the anti-inflammatory 
and antioxidant roots of curcumin and ginger, both at a dose 
of 200 mg/kg, in an experimental model of adjuvant-induced 
arthritis. They found that both rhizomes were able to reduce the 
incidence and severity of arthritis by increasing and decreasing 
proinflammatory and anti-inflammatory cytokines, respectively, 
and activating the antioxidant defense systems. When compared 
to curcumin extract of ginger and indomethacin, they found that 
curcumin showed an anti-arthritic effect that was superior that of 
other substances, particularly when administered from the day of 
the induction of arthritis. They concluded that the results proved 
that the anti-inflammatory and antioxidant effects of curcumin are 
stronger than those of ginger and indomethacin. Its low cost and 
lack of adverse effects make the substance potentially effective 
in treating arthritis22. Phase 1 studies have shown that even high 
doses of curcumin (12 g/day), although safe, present with low 
availability in serum16. Because the extract of Curcuma longa is 
not water soluble, we chose to dissolve it in corn oil. Other authors 
have chosen to dissolve the plant extract in olive oil19. Therefore, 
it is possible that the vehicle used has also interfered with the 
absorption. A previous study demonstrated that the use of pure 
oral powder of a commercialized extract containing 94% of the 
three main curcuminoids is more potent in preventing arthritis 
than essential oil substances31. It is possible that the administration 
of curcumin parenteral could provide higher availability; however, 
this type of administration diminishes the advantage of using the 
substance over other drug options for the treatment of arthritis. 
The use of nanoparticles or curcumin involved in phospholipid 
complexes, or the synthesis of analogous substances, appears 
to have solved the problems of low bioavailability because they 
favor the absorption and metabolism delay31. 
In this this study when were counted the number of 
neutrophils per field in the control (positive and negative) and 
the experimental groups (curcumin, prednisone 1 mg/kg and 
8 mg/kg) six hours after the induction of arthritis by zymosan 
was found lower number of neutrophils per field in negative 
control group than the positive control group (p<0.01). When 
comparing animals subjected to gastric gavage with curcumin 
and prednisone (1 mg/kg) with the positive controls, we found 
a significant reduction in the numbers of neutrophils per field 
(p<0.01). After 12 hours of the intervention with curcumin and 
the two doses of prednisone, we could not find a reduction in the 
number of neutrophils compared with the positive control group, 
but a significantly higher number was observed when compared 
with the negative control. After 48 hours of intervention, we 
confirmed that animals subjected to gastric gavage with 1 mg/
kg of prednisone had a lower number of neutrophils counted 
per field than the positive control group (p<0.01). After 48 
hours, the intervention of both substances did not reduce 
the number of neutrophils when compared with the positive 
control group. In other words, the results of this study shown 
that curcumin has early anti-inflammatory activity. It’s reduces 
the inflammation in the joint within the first six hours after the 
induction of arthritis, showing similar therapeutic efficacy even 
at doses comparable to steroids immunosuppressive doses and 
exceeding the anti-inflammatory effects observed with GC. 
However, after 12 and 24 hours, the anti-inflammatory effects 
of curcumin become similar to those of prednisone at both doses 
and do not alter the degree of inflammation. These findings 
may be related to low plasma and tissue levels of curcumin 
due to the low absorption by the digestive tract, and rapid 
systemic metabolism and elimination18. It is possible that the 
use of drugs by the parenteral route, dissolved in lipid vehicles 
capable of intravenous administration, can enhance the activity 
of the substance during that period. 
The results of this study suggest that curcumin may be 
a useful drug for treating the acute phase of arthritis; however, 
additional studies have to be performed to improve the effectiveness 
of the substance. Research comparing increasing concentrations of 
the drug through different routes of administration, and especially 
improving their bioavailability, are still required to enable the use 
of curcumin.
Conclusion
Oral administration of curcumin may be a useful strategy 
for treating the initial phase of zymosan-induced arthritis.
Oral administration of curcumin (Curcuma longa) can attenuate the neutrophil 
inflammatory response in zymosan-induced arthritis in rats
Acta Cirúrgica Brasileira - Vol. 29 (11) 2014 - 733
References
1. Lawrence RC, Felson DT, Helmick C G, Arnold LM, Choi H, Deyo 
RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, 
Katz JN, Kremers HM, Wolfe F. National Arthritis Data Workgroup. 
Estimates of the prevalence of arthritis and other rheumatic 
conditions in the United States. Part II. Arthritis Rheum. 2008 
Jan;58(1):26-35. doi: 10.1002/art.23176.
2. Mahajan A, Verma S, Tandon V. Osteoarthritis. J Ass Physicians 
India. 2005 Jul;53:634-41. PMID: 16190135.
3. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res 
Clin Rheumatol. 2006 Feb;20(1):3-25. PMID:16483904.
4. Dibonaventura M, Gupta S, McDonald M, Sadosky A. Evaluating 
the health and economic impact of osteoarthritis pain in the 
workforce: results from the National Health and Wellness Survey. 
BMC Musculoskelet Disord. 2011 Apr 28;12:83. doi: 10.1186/1471-
2474-12-83.
5. Rocha FA, Andrade LE, Jancar S. Immune complex induced arthritis 
in rats: role of lipid mediators on cell infiltration. Med Inflam. 1996; 
5(2):104-9. PMID: 18475706.
6. Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen 
species in homeostasis and degradation of cartilage. Osteoarthritis 
Cartilage. 2003 Oct;11(10):747-55. PMID:13129694.
7. Fermor B, Christensen SE, Youn I, Cernanec JM, Davies CM, 
Weinberg JB. Oxygen, nitric oxide and articular cartilage. Eur Cell 
Mater. 2007 Apr 11;13:56-65;discussion 65. PMID: 17427142.
8. Jurenka JS. Anti-inflammatory properties of curcumin, a major 
constituent of Curcuma longa: A review of pre-clinical and clinical 
research. Altern Med Rev. 2009 Jun;14(2):141-53. PMID:19594223.
9. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, 
placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, 
on osteoarthritis of the knees. Clin Rheumatol. 2004 Oct;10(5):236-
45. PMID: 17043520.
10. Park C, Moon DO, Choi IW, Choi BT, Nam TJ, Rhu CH, Kwon 
TK, Lee WH, Kim GY, Choi YH. Curcumin induces apoptosis 
and inhibits prostaglandin E(2) production in synovial fibroblasts 
of patients with rheumatoid arthritis. Int J Mol Med. 2007 
Sep;20(3):365-72. PMID: 17671742.
11. Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Sólyom 
AM, Timmermann BN. Turmeric extracts containing curcuminoids 
prevent experimental rheumatoid arthritis. J Nat Prod. 2006 
Mar;69(3):351-5. PMID: 16562833.
12. Chaves HV, Ribeiro R de A, de Souza AM, Rodrigues e Silva 
AA, Gomes AS, Vale ML, Bezerra MM, Brito GA. Experimental 
model of zymosan-induced arthritis in the rat temporomandibular 
joint: role of nitric oxide and neutrophils J Biomed Biotechnol. 
2011;2011:707985. doi: 10.1155/2011/707985.
13. Keystone EC, Schorlemmer HU, Pope C, Allison AC. Zymosan-
induced arthritis: a model of chronic proliferative arthritis following 
activation of the alternative pathway of complement. Arthritis 
Rheum. 1977 Sep-Oct;20(7):1397-401. PMID: 911357.
14. Gegout P, Gillet P, Terlain B, Netter P. Zymosan induced 
arthritis in rats II. Effects of antiinflammatory drugs. Life Sci. 
1995;56(20):PL389-94. PMID: 7723595.
15. Berner J, Gabay C. Best practice use of corticosteroids in rheumatoid 
arthritis. Rev Med Suisse. 2014 Mar 12;10(421):603-6, 608. PMID 
24701713.
16. Narendhirakannan RT, Limmy TP. Anti-inflammatory and anti-
oxidant properties of Sida rhombifolia stems and roots in adjuvant 
induced arthritic rats. Immunopharmacol Immunotoxicol. 2012 
Apr;34(2):326-36. doi: 10.3109/08923973.2011.605142.
17. Aggarwal BB, Sundaram C, Malani N, Ichikaw, H. Curcumin: 
the Indian solid gold. Adv Exp Med Biol. 2007;595:1-75. PMID: 
17569205.
18. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 
Bioavailability of curcumin: problems and promises. Mol Pharm. 
2007 Nov-Dec;4(6):807-18. PMID: 17999464.
19. Taty Anna K, Elvy Suhana MR, Faizah O, Hamzaini AH. Anti-
inflammatory effect of Curcuma longa (turmeric) on collagen-
induced arthritis: an anatomico-radiological study. Clin Ter. 
2011;162(3):201-7. PMID: 21717043.
20. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the 
roots. Ann N Y Acad Sci. 2005 Nov;1056:206-17. PMID: 16387689.
21. Samuhasaneeto S, Thong-Ngam D, Kulaputana O, Suyasunanont 
D, Klaikeaw N. Curcumin decreased oxidative stress, inhibited NF-
kappaB activation, and improved liver pathology in ethanol-induced 
liver injury in rats. J Biomed Biotechnol. 2009;2009:981963. doi: 
10.1155/2009/981963.
22. Ramadan G, AL-Kahtani MA, EL-Sayed WM. Anti-inflammatory 
and anti-oxidant properties of Curcuma longa (turmeric) versus 
Zingiber officinale (ginger) rhizomes in rat adjuvant-induced 
arthritis. Inflammation. 2011 Aug;34(4):291-301. doi: 10.1007/
s10753-010-9278-0.
23. Park C, Moon DO, Choi IW, Choi BT, Nam TJ, Rhu CH, Kwon 
TK, Lee WH, Kim GY, Choi YH. Curcumin induces apoptosis 
and inhibits prostaglandin E(2) production in synovial fibroblasts 
of patients with rheumatoid arthritis. Int J Mol Med. 2007 
Sep;20(3):365-72. PMID: 17671742.
24. Mun SH, Kim HS, Kim JW, Ko NY, Kim DOK, Lee BY, Kim B, 
Won HS, Shin HS, Han JW, Lee HY, Kim YM, Choi WS. Oral 
administration of curcumin suppresses production of matrix 
metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-
induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway. J 
Pharmacol Sci. 2009 Sep;111(1):13-21. PMID: 19763044.
25. Moon DO, Kim MO, Choi YH, Park YM, Kim GY. Curcumin 
attenuates inflammatory response in IL-1beta-induced human 
synovial fibroblasts and collagen-induced arthritis in mouse model. 
Int Immunopharmacol. 2010 May;10(5):605-10. doi: 10.1016/j.
intimp.2010.02.011.
26. Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmermann BN. The 
effect of turmeric extracts on inflammatory mediator production. 
Phytomedicine. 2005 Jun;12(6-7):445–52. PMID: 16008121.
27. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane 
(curcumin), a non-steroidal antiinflammatory agent. J Pharm 
Pharmacol. 1973 Jun;25(6):447-52. PMID: 4146582.
28. Baker CL Jr, Ferguson CM. Future treatment of osteoarthritis. 
Orthopedics. 2005 Feb;28(2 Suppl):s227-34. PMID: 15747611.
29. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. 
Modulation of inflammatory mediators by ibuprofen and curcumin 
treatment during chronic inflammation in rat. Immunopharmacol 
Immunotoxicol. 2003 May;25(2):213-24. PMID: 12784914.
30. Banji D, Pinnapureddy J, Banji OJ, Saidulu A, Hayath MS. 
Synergistic activity of curcumin with methotrexate in ameliorating 
Freund’s Complete Adjuvant induced arthritis with reduced 
hepatotoxicity in experimental animals. Eur J Pharmacol. 2011 Oct 
1;668(1-2):293-8. doi: 10.1016/j.ejphar.2011.06.006.
31. Funk JL, Frye JB, Oyarzo JN, Kuscuoglu N, Wilson J, McCaffrey 
G, Stafford G, Chen G, Lantz RC, Jolad SD, Sólyom AM, Kiela PR, 
Timmermann BN. Efficacy and mechanism of action of turmeric 
supplements in the treatment of experimental arthritis. Arthritis 
Rheum. 2006 Nov;54(11):3452-64. PMID: 17075840.
32. Jancinová V, Perecko T, Nosál R, Kostálová D, Bauerová K, 
Drábiková K. Decreased activity of neutrophils in the presence of 
diferuloylmethane (curcumin) involves protein kinase C inhibition. 
Eur J Pharmacol, 2009 Jun 10;612(1-3):161-6. doi: 10.1016/j.
ejphar.2009.03.080.
Nonose N et al.
734 - Acta Cirúrgica Brasileira - Vol. 29 (11) 2014
33. Joe B, Rao UJ, Lokesh BR. Presence of an acidic glycoprotein in the 
serum of arthritic rats: modulation by capsaicin and curcumin. Mol 
Cell Biochem. 1997 Apr;169(1-2):125-34. PMID: 9089639.
Correspondence:
Prof. Carlos Augusto Real Martinez
Rua Rui Barbosa, 255/32




Received: June 19, 2014
Review: Aug 18, 2014
Accepted: Sep 22, 2014
Conflict of interest: none
Financial source: Sao Paulo Research Foundation (FAPESP). Process Nº 
2010/12492-7
1Research performed at Postgraduate Program in Health Sciences, Sao 
Francisco University (USF), Bragança Paulista-SP, Brazil. Part of Master 
degree thesis, Postgraduate Program in Health Sciences, USF. Tutor: Car-
los Augusto Real Martinez.
